BCIQ Profiles

Company Profile ReportTarget Profile Report
0810 COVID roundup
BioCentury & Getty Images

Remdesivir heads for FDA review as Gilead continues to build manufacturing pipeline 

Plus data from Omeros, PTC and a call to make mAbs accessible

Aug 11, 2020 | 2:38 AM GMT

As Gilead continues to expand its manufacturing capabilities for Veklury, the company has moved a step closer to gaining full approval of the therapy in the U.S. for COVID-19. The company announced its NDA submission for the antiviral

Read the full 726 word article